Bristol Myers strikes a $13 billion deal, presidential experiments, the NIH funds under-represented testing, and Sophia Genetics raises $110 million. Sponsors https://www.thescopemethod.com Story References…
Another Alzheimer’s failure, COVID19 updates, two stories in the supplements space, and Taysha goes public. Sponsors https://www.thescopemethod.com Story References https://ir.acimmune.com/news-releases/news-release-details/ac-immune-reports-top-line-results-tauriel-phase-2-trial https://www.medrxiv.org/content/10.1101/2020.09.23.20199604v1.full.pdf https://www.cell.com/cell-metabolism/fulltext/S1550-4131(20)30417-4 https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239799 https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-pricing-initial-public-offering Music…
Finch does probiotics the expensive way, lipid nanoparticles, a followup on transparency, and LAVA gains immuno-therapy support. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://www.businesswire.com/news/home/20200916005915/en/Moderna-and-Vertex-Establish-New-Collaboration-to-Treat-Cystic-Fibrosis-Using-Gene-Editing https://finchtherapeutics.com/blog/finch-therapeutics-announces-90-million-financing https://www.modernatx.com/sites/default/files/mRNA-1273-P301-Protocol.pdf https://www.businesswire.com/news/home/20200916005913/en/LAVA-Therapeutics-Announces-83-million-Series-C-Financing-to-Advance-Novel-Immuno-Oncology-Programs Music…
This week, vaccines and shark statistics, are noses the ultimate pipedream, and eye drops to replace eye-glasses. Sponsors https://www.thescopemethod.com Story References https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2020/statement-on-astrazeneca-oxford-sars-cov-2-vaccine-azd1222-covid-19-vaccine-trials-temporary-pause.html https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2020/covid-19-vaccine-azd1222-clinical-trials-resumed-in-the-uk.html https://www.globenewswire.com/news-release/2020/09/10/2091685/0/en/Satsuma-Pharmaceuticals-Announces-Topline-Results-from-EMERGE-Phase-3-Trial-of-STS101-for-the-Acute-Treatment-of-Migraine.html…
Roche earns FDA approval for a combined flu/COVID diagnostic, I-Mab signs with Abbvie for $2 billion, PPD partners to treat lupus, and BioNTech/Pfizer add more…
This week, we take a break from our normal news cycle to focus on one big idea; healthcare is politics. But first, a quick update.…
Johnson & Johnson acquires Momenta, the White House and FDA disagree, and the emergence of decentralized clinical trial management. Sponsorswww.thescopemethod.com Story Referenceshttps://www.momentapharma.com/investors-and-news/press-releases/press-releases-details/2020/Momenta-Enters-Definitive-Agreement-with-Johnson–Johnson/https://www.hhs.gov/coronavirus/testing/recission-guidances-informal-issuances-premarket-review-lab-tests/index.htmlhttp://www.science37.com/solutions/ Music by Luke…
Samsung Biologics builds big, Modern (again), microparticles for timed-release chemotherapy, and Qiagen says ‘no’ to acquisitions. Sponsorswww.thescopemethod.com Story Referenceshttps://samsungbiologics.com/front/en/mediaCenter/pressReleasesView.do?boardSeq=781&schBoardCtgryCcd=&schString=&schBoardYear=&boardDtm=1597071600000&page=1#https://investors.modernatx.com/news-releaseshttps://stm.sciencemag.org/content/12/556/eaaz6606https://www.fiercebiotech.com/medtech/thermo-fisher-s-12-5b-deal-for-qiagen-flops-as-covid-19-test-demand-lights-new-path-forward Music by Luke Goodsonwww.soundcloud.com/lukegoodson The Niche…
Biogen and Denali partner for Parkinson’s, the US pushes American-based drug manufacturing, and the secret to Parasitic Sexual Partners uncovered. Sponsorswww.thescopemethod.com Story Referenceshttps://investors.biogen.com/news-releases/news-release-details/biogen-and-denali-collaborate-lrrk2-program-parkinsons-diseasehttps://science.sciencemag.org/content/early/2020/07/29/science.aaz9445https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832911/https://www.whitehouse.gov/presidential-actions/executive-order-ensuring-essential-medicines-medical-countermeasures-critical-inputs-made-united-states/ Music by…
We review a few of the big winners from operation warp speed, Merck continues to be quietly successful, and a new CAR T treatment, Tecartus,…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
